{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:16:43Z","timestamp":1778581003228,"version":"3.51.4"},"reference-count":40,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Eker rats heterozygous for a dominant germline mutation in the tuberous sclerosis 2 (Tsc2) tumor suppressor gene were used as a model to study renal carcinogenesis. Eker and corresponding wild-type rats were exposed to genotoxic aristolochic acid (AA) or non-genotoxic ochratoxin A (OTA) to elucidate early carcinogen-specific gene expression changes and to test whether Eker rats are more sensitive to carcinogen-induced changes in gene expression. Male Eker and wild-type rats were gavaged daily with AA (10 mg\/kg body weight) or OTA (210 \u03bcg\/kg body weight). After 1, 3, 7, and 14 days of exposure, renal histopathology, tubular cell proliferation, and Affymetrix gene expression profiles from renal cortex\/outer medulla were analyzed. AA-treated Eker and wild-type rats were qualitatively comparable in all variables assessed, suggesting a Tsc2-independent mechanism of action. OTA treatment resulted in slightly increased cortical pathology and significantly elevated cell proliferation in both strains, although Eker rats were more sensitive. Deregulated genes involved in the phosphatidylinositol 3-kinase-AKT-Tsc2-mammalian target of rapamycin signaling, among other important genes prominent in tumorigenesis, in conjunction with the enhanced cell proliferation and presence of preneoplastic lesions suggested involvement of Tsc2 in OTA-mediated toxicity and carcinogenicity, especially as deregulation of genes involved in this pathway was more prominent in the Tsc2 mutant Eker rat. [Cancer Res 2007;67(9):4052\u201368]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-3587","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T15:18:46Z","timestamp":1178291926000},"page":"4052-4068","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Carcinogen-Specific Gene Expression Profiles in Short-term Treated Eker and Wild-type Rats Indicative of Pathways Involved in Renal Tumorigenesis"],"prefix":"10.1158","volume":"67","author":[{"given":"Kerstin","family":"Stemmer","sequence":"first","affiliation":[{"name":"1Human and Environmental Toxicology, University of Konstanz, Konstanz, Germany and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Ellinger-Ziegelbauer","sequence":"additional","affiliation":[{"name":"2Molecular and Special Toxicology, Bayer Healthcare AG, Wuppertal, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Juergen","family":"Ahr","sequence":"additional","affiliation":[{"name":"2Molecular and Special Toxicology, Bayer Healthcare AG, Wuppertal, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Dietrich","sequence":"additional","affiliation":[{"name":"1Human and Environmental Toxicology, University of Konstanz, Konstanz, Germany and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2007,5,4]]},"reference":[{"key":"2022061623350647300_B1","doi-asserted-by":"crossref","unstructured":"Yeung RS, Xiao GH, Jin F, et al. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci U S A\u20081994; 91: 11413\u20136.","DOI":"10.1073\/pnas.91.24.11413"},{"key":"2022061623350647300_B2","doi-asserted-by":"crossref","unstructured":"Hino O, Kobayashi E, Hirayama Y, et al. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2). Mol Carcinog\u20081995; 14: 23\u20137.","DOI":"10.1002\/mc.2940140106"},{"key":"2022061623350647300_B3","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet\u20081995; 9: 70\u20134.","DOI":"10.1038\/ng0195-70"},{"key":"2022061623350647300_B4","doi-asserted-by":"crossref","unstructured":"Everitt JI, Goldsworthy TL, Wolf DC, Walker CL. Hereditary renal cell carcinoma in the Eker rat: a unique animal model for the study of cancer susceptibility. Toxicol Lett\u20081995; 82-83: 621\u20135.","DOI":"10.1016\/0378-4274(95)03506-0"},{"key":"2022061623350647300_B5","doi-asserted-by":"crossref","unstructured":"Yeung RS, Xiao GH, Everitt JI, Jin F, Walker CL. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol Carcinog\u20081995; 14: 28\u201336.","DOI":"10.1002\/mc.2940140107"},{"key":"2022061623350647300_B6","doi-asserted-by":"crossref","unstructured":"Walker C, Goldsworthy TL, Wolf DC, Everitt J. Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. Science\u20081992; 255: 1693\u20135.","DOI":"10.1126\/science.1553556"},{"key":"2022061623350647300_B7","doi-asserted-by":"crossref","unstructured":"Wolf DC, Goldsworthy TL, Janszen DB, et al. Promotion by sodium barbital induces early development but does not increase the multiplicity of hereditary renal tumors in Eker rats. Carcinogenesis\u20082000; 21: 1553\u20138.","DOI":"10.1093\/carcin\/21.8.1553"},{"key":"2022061623350647300_B8","doi-asserted-by":"crossref","unstructured":"Mak BC, Yeung RS. The tuberous sclerosis complex genes in tumor development. Cancer Invest\u20082004; 22: 588\u2013603.","DOI":"10.1081\/CNV-200027144"},{"key":"2022061623350647300_B9","doi-asserted-by":"crossref","unstructured":"Mengs U, Lang W, Poch J-A. The carcinogenic action of aristolochic acid in rats. Arch Toxicol\u20081982; 51: 107\u201319.","DOI":"10.1007\/BF00302751"},{"key":"2022061623350647300_B10","doi-asserted-by":"crossref","unstructured":"Boorman GA, McDonald MR, Imoto S, Persing R. Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol Pathol\u20081992; 20: 236\u201345.","DOI":"10.1177\/019262339202000210"},{"key":"2022061623350647300_B11","doi-asserted-by":"crossref","unstructured":"Schmeiser HH, Scherf HR, Wiessler M. Activating mutations at codon 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice. Cancer Lett\u20081991; 59: 139\u201343.","DOI":"10.1016\/0304-3835(91)90178-K"},{"key":"2022061623350647300_B12","doi-asserted-by":"crossref","unstructured":"Cheng CL, Chen KJ, Shih PH, et al. Chronic renal failure rats are highly sensitive to aristolochic acids, which are nephrotoxic and carcinogenic agents. Cancer Lett\u20082006; 232: 236\u201342.","DOI":"10.1016\/j.canlet.2005.02.021"},{"key":"2022061623350647300_B13","doi-asserted-by":"crossref","unstructured":"Lord GM, Hollstein M, Arlt VM, et al. DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am J Kidney Dis\u20082004; 43: e11\u20137.","DOI":"10.1053\/j.ajkd.2003.11.024"},{"key":"2022061623350647300_B14","doi-asserted-by":"crossref","unstructured":"Dong H, Suzuki N, Torres MC, et al. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling\/polyacrylamide gel electrophoresis analysis. Drug Metab Dispos\u20082006; 34: 1122\u20137.","DOI":"10.1124\/dmd.105.008706"},{"key":"2022061623350647300_B15","doi-asserted-by":"crossref","unstructured":"Pfau W, Schmeiser HH, Wiessler M. Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis\u20081990; 11: 313\u20139.","DOI":"10.1093\/carcin\/11.2.313"},{"key":"2022061623350647300_B16","doi-asserted-by":"crossref","unstructured":"Stiborova M, Frei E, Sopko B, et al. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase. Carcinogenesis\u20082003; 24: 1695\u2013703.","DOI":"10.1093\/carcin\/bgg119"},{"key":"2022061623350647300_B17","doi-asserted-by":"crossref","unstructured":"Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis\u20082002; 17: 265\u201377.","DOI":"10.1093\/mutage\/17.4.265"},{"key":"2022061623350647300_B18","doi-asserted-by":"crossref","unstructured":"Mantle P, Kulinskaya E, Nestler S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit Contam\u20082005; 22 Suppl 1: 58\u201364.","DOI":"10.1080\/02652030500358431"},{"key":"2022061623350647300_B19","doi-asserted-by":"crossref","unstructured":"Mally A, Pepe G, Ravoori S, et al. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem Res Toxicol\u20082005; 18: 1253\u201361.","DOI":"10.1021\/tx049650x"},{"key":"2022061623350647300_B20","doi-asserted-by":"crossref","unstructured":"Kamp HG, Eisenbrand G, Janzowski C, et al. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol Nutr Food Res\u20082005; 49: 1160\u20137.","DOI":"10.1002\/mnfr.200500124"},{"key":"2022061623350647300_B21","doi-asserted-by":"crossref","unstructured":"Rennebeck G, Kleymenova EV, Anderson R, et al. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci U S A\u20081998; 95: 15629\u201334.","DOI":"10.1073\/pnas.95.26.15629"},{"key":"2022061623350647300_B22","doi-asserted-by":"crossref","unstructured":"Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat Res\u20082005; 575: 61\u201384.","DOI":"10.1016\/j.mrfmmm.2005.02.004"},{"key":"2022061623350647300_B23","unstructured":"Dietrich DR, Swenberg JA. The presence of alpha 2u-globulin is necessary for d-limonene promotion of male rat kidney tumors. Cancer Res\u20081991; 51: 3512\u201321."},{"key":"2022061623350647300_B24","doi-asserted-by":"crossref","unstructured":"Chen T, Guo L, Zhang L, et al. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics\u20082006; 7 Suppl 2: S20.","DOI":"10.1186\/1471-2105-7-S2-S20"},{"key":"2022061623350647300_B25","doi-asserted-by":"crossref","unstructured":"Rasonyi T, Schlatter J, Dietrich DR. The role of alpha2u-globulin in ochratoxin A induced renal toxicity and tumors in F344 rats. Toxicol Lett\u20081999; 104: 83\u201392.","DOI":"10.1016\/S0378-4274(98)00347-6"},{"key":"2022061623350647300_B26","doi-asserted-by":"crossref","unstructured":"Sionov RV, Haupt Y. The cellular response to p53: the decision between life and death. Oncogene\u20081999; 18: 6145\u201357.","DOI":"10.1038\/sj.onc.1203130"},{"key":"2022061623350647300_B27","doi-asserted-by":"crossref","unstructured":"Sen B, Wolf DC, Hester SD. The transcriptional profile of the kidney in Tsc2 heterozygous mutant Long Evans (Eker) rats compared to wild-type. Mutat Res\u20082004; 549: 213\u201324.","DOI":"10.1016\/j.mrfmmm.2003.12.023"},{"key":"2022061623350647300_B28","doi-asserted-by":"crossref","unstructured":"Liang J, Slingerland JM. Multiple roles of the PI3K\/PKB (Akt) pathway in cell cycle progression. Cell Cycle\u20082003; 2: 339\u201345.","DOI":"10.4161\/cc.2.4.433"},{"key":"2022061623350647300_B29","doi-asserted-by":"crossref","unstructured":"Dietrich DR, Swenberg JA. Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxic agents: predictive nature and comparison to lesions induced by genotoxic carcinogens. Mutat Res\u20081991; 248: 239\u201360.","DOI":"10.1016\/0027-5107(91)90060-2"},{"key":"2022061623350647300_B30","doi-asserted-by":"crossref","unstructured":"Luhe A, Hildebrand H, Bach U, Dingermann T, Ahr HJ. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol Sci\u20082003; 73: 315\u201328.","DOI":"10.1093\/toxsci\/kfg073"},{"key":"2022061623350647300_B31","doi-asserted-by":"crossref","unstructured":"Marin-Kuan M, Nestler S, Verguet C, et al. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat. Toxicol Sci\u20082006; 89: 120\u201334.","DOI":"10.1093\/toxsci\/kfj017"},{"key":"2022061623350647300_B32","doi-asserted-by":"crossref","unstructured":"Cavin C, Delatour T, Marin-Kuan M, et al. Reduction in antioxidant defences may contribute to ochratoxin a toxicity and carcinogenicity. Toxicol Sci\u20082007; 96: 30\u20139. Epub 2006 Nov 16.","DOI":"10.1093\/toxsci\/kfl169"},{"key":"2022061623350647300_B33","doi-asserted-by":"crossref","unstructured":"Kaimori JY, Takenaka M, Nakajima H, et al. Induction of glia maturation factor-\u03b2 in proximal tubular cells leads to vulnerability to oxidative injury through the p38 pathway and changes in antioxidant enzyme activities. J Biol Chem\u20082003; 278: 33519\u201327.","DOI":"10.1074\/jbc.M301552200"},{"key":"2022061623350647300_B34","doi-asserted-by":"crossref","unstructured":"Habib SL, Phan MN, Patel SK, et al. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat. Carcinogenesis\u20082003; 24: 573\u201382.","DOI":"10.1093\/carcin\/24.3.573"},{"key":"2022061623350647300_B35","doi-asserted-by":"crossref","unstructured":"Horvath A, Upham BL, Ganev V, Trosko JE. Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Toxicon\u20082002; 40: 273\u201382.","DOI":"10.1016\/S0041-0101(01)00219-7"},{"key":"2022061623350647300_B36","doi-asserted-by":"crossref","unstructured":"Gekle M, Sauvant C, Schwerdt G. Ochratoxin A at nanomolar concentrations: a signal modulator in renal cells. Mol Nutr Food Res\u20082005; 49: 118\u201330.","DOI":"10.1002\/mnfr.200400062"},{"key":"2022061623350647300_B37","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell\u20082000; 100: 57\u201370.","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"2022061623350647300_B38","doi-asserted-by":"crossref","unstructured":"Thomas GV. mTOR and cancer: reason for dancing at the crossroads? Curr Opin Genet Dev\u20082006; 16: 78\u201384.","DOI":"10.1016\/j.gde.2005.12.003"},{"key":"2022061623350647300_B39","doi-asserted-by":"crossref","unstructured":"Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell\u20082005; 121: 179\u201393.","DOI":"10.1016\/j.cell.2005.02.031"},{"key":"2022061623350647300_B40","doi-asserted-by":"crossref","unstructured":"Stemmer K, Ellinger-Ziegelbauer H, Lotz K, Ahr HJ, Dietrich DR. Establishment of a protocol for the gene expression analysis of laser microdissected rat kidney samples with Affymetrix genechips. Toxicol Appl Pharmacol\u20082006; 217: 134\u201342.","DOI":"10.1016\/j.taap.2006.07.012"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/9\/4052\/2579920\/4052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/9\/4052\/2579920\/4052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:02:17Z","timestamp":1655424137000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/9\/4052\/534373\/Carcinogen-Specific-Gene-Expression-Profiles-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2007,5,4]]},"published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-3587","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22371681.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371672","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371681","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371669.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371666","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371675","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371669","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371672.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371678","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371675.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371678.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22371666.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496881.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496881","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}